Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine with Radiotherapy for Local Relapse Breast Cancer
NCT00434941Phase 2Terminated
- Sponsor
- GEICAM
- Start
- Sep 2007
- Primary completion
- Jan 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by GEICAM. Started Sep 2007; status: terminated.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00434941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434941.